Warner Chilcott Announces Approval of Doryx Delayed-Release 150 mg Tablets

Warner Chilcott Limited (Nasdaq:WCRX) announced today that the Food and Drug Administration (FDA) has approved a 150 mg strength of DORYX(r) (doxycycline hyclate) Delayed-Release Tablets.

The whole story can be read here.